Camrelizumab (anti-PD-1), 程序性细胞死亡蛋白 1 拮抗剂

CAS: 1798286-48-2 货号: C412007
有货
级别和纯度: 无动物源 ? 无动物源(Animal Free)—— 不含动物源成分生产,降低污染风险。适用于避免动物源材料的生物制造和培养。 无载体 ? 无载体(Carrier Free)—— 不含添加的载体蛋白/稳定剂。当载体(如 BSA)会干扰偶联或敏感检测时使用。 重组 ? 重组(Recombinant)—— 通过重组表达生产,序列确定、批次稳定。适用于来源明确、无动物源的可重现蛋白。 已验证 ? 已验证级 —— 发布前在特定应用中确认性能。当需要试剂按声称工作的书面保证时使用。 ExactAb™ ? ExactAb™ —— 阿拉丁强调精准和验证质量的抗体系列。适用于可靠、特异性经验证的抗体应用。 低内毒素 ? 低内毒素级 —— 内毒素降至受控低水平。适用于高内毒素会造成干扰的敏感生物工作。 无叠氮钠 ? 无叠氮(Azide Free)—— 不含叠氮化钠防腐剂。适用于叠氮有毒或有抑制作用的偶联、细胞工作或检测。 ≥95%(SDS-PAGE&SEC-HPLC) 见COA
应用
Animal Model, ELISA, Flow Cytometry, Functional Assay
宿主种属
人(Human)
种属反应性
人(Human), 食蟹猴(Cynomolgus monkey)
亚型
Human IgG4SP
偶联
Unconjugated
★
规格
库存
价格
数量
100μg
C412007-100μg
现货 Stock Image
¥339.90
1mg
C412007-1mg
现货 Stock Image
¥1,699.90
5mg
C412007-5mg
现货 Stock Image
¥5,667.90
10mg
C412007-10mg
期货 Stock Image
¥7,999.90
请输入您要添加的产品数量
🧪

为什么选择此级别

ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。

🌡

储存与运输

-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。

📋

质量文档

SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。

📚

文献证明

在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。

概述

Camrelizumab 是一种有效的抗 PD-1/PD-L1 活性分子,可用于癌症研究,包括非小细胞肺癌、食管鳞状细胞癌、霍奇金淋巴瘤和晚期肝癌等。

Information

Camrelizumab is a potent anti-PD-1 /PD-L1 active molecule that can be used in cancer research, including non-small cell lung cancer, esophageal squamous cell carcinoma, Hodgkin lymphoma, and advanced liver cancer.

Purity

>95% (SDS-PAGE&SEC)

Endotoxin Level

< 1.0EU/mg

规格

产品名称
Camrelizumab (anti-PD-1), 程序性细胞死亡蛋白 1 拮抗剂
别名
卡瑞利珠单抗 | PD-1抗体 | PD-1单克隆抗体 | PD-1药靶抗体 | PDCD1抗体 | PDCD1单克隆抗体 | PDCD1药靶抗体 | CD279抗体 | CD279单克隆抗体 | CD279药靶抗体
英文别名
SHR-1210 | CD279 antigen | CD279 | hPD-1 | PD1 | PD-1 | PD1hPD-l | PDCD1 | programmed cell death 1 | programmed cell death protein 1 | Protein PD-1 | SLEB2 | CD279 antibody | CD279 antigen antibody | hPD 1 antibody | hPD l antibody | hPD-1 antibody | hSLE
规格或纯度
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
生化机理
Possible cell death inducer, in association with other factors.
宿主种属
人(Human)
特异性
PDCD1
应用
Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR)
种属反应性
人(Human),食蟹猴(Cynomolgus monkey)
偶联
Unconjugated
作用类型
拮抗剂
作用机制
程序性细胞死亡蛋白 1 拮抗剂
抗体类型
Primary antibody
克隆类型
重组抗体
Format
Whole IgG
亚型
Human IgG4SP
轻链亚型
kappa
纯化方法
Protein A purified
纯度
>95%
来源
CHO supernatant
浓度
见COA
CAS编号和信息
1798286-48-2
分子类型
抗体
储存与运输
物理外观
Liquid
储存缓冲液
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片

Camrelizumab (anti-PD-1) (C412007) - Flow Cytometry
Flow Cytometry analysis of 5μg/mL PHA stimulated 3 days human peripheral blood lymphocytes labelling PD-1 (red) with Camrelizumab (anti-PD-1) (C412007) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.

Camrelizumab (anti-PD-1) (C412007) - Flow Cytometry
Flow Cytometry analysis of MOLT-4 cells labelling PD-1 (red) with Camrelizumab (anti-PD-1) (C412007). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Camrelizumab (anti-PD-1) (C412007) - SEC
The purity of Camrelizumab (anti-PD-1) (C412007) is more than 95% verified by HPLC.

Camrelizumab (anti-PD-1) (C412007) - ELISA
Immobilized TARGET at 2 μg/mL can bind Camrelizumab (anti-PD-1) (C412007) with the EC₅₀ of 8.25 ng/mL.

Camrelizumab (anti-PD-1) (C412007) - ELISA
Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Camrelizumab (anti-PD-1) (C412007) with the EC50 of 10.39 ng/mL.

技术文档

📋 安全数据表 (SDS)

全面的危险、操作、储存及法规合规文件。

下载 SDS →

✅ 分析证书 (COA)

批次质量数据。输入批号以获取对应 COA。

查询 COA →

📊 产品数据表

产品规格和应用的快速参考摘要。

查看数据表 →

🔬 规格说明书

该级别的完整质量属性和验收标准。

查看规格说明 →

高级数据

关联靶点(人)
PDCD1 Tclin 程序性细胞死亡蛋白 1(Programmed cell death protein 1) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PDCD1 Tclin Programmed cell death protein 1 (14 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
作用机制
作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到8个结果

批号(Lot Number) 证书类型 货号
ZJ24F1011682 分析证书 C412007
ZJ23F1202074 分析证书 C412007
ZJ23F1202075 分析证书 C412007
ZJ25F0319944 分析证书 C412007
ZJ25F0319945 分析证书 C412007
ZJ24F1215870 分析证书 C412007
ZJ24F1113249 分析证书 C412007
ZJ24F0607389 分析证书 C412007
溶液计算器

相关产品

Pembrolizumab (anti-PD-1)
Nivolumab (anti-PD-1)
Cemiplimab (anti-PD-1)
Goat Anti-Human IgG H&L (HRP)
Mouse Anti-Human IgG Antibody
Mouse Anti-Human IgG H&L (HRP)
Mouse Anti-Human IgM Antibody
Human IgG
Goat Anti-Human IgG Antibody
Spartalizumab (anti-PD-1)
Sintilimab (anti-PD-1)
Penpulimab (anti-PDCD1)
Zimberelimab (anti-PD-1)
Dostarlimab (anti-PD-1)
Retifanlimab (anti-PD-1)
Pidilizumab (anti-PD-1)
Tislelizumab (anti-PDCD1)
Mouse Anti-Human IgA H&L Antibody
Goat Anti-Human IgG (HRP)
Goat Anti-Human IgG (Biotin)
PD1 Mouse mAb
Goat Anti-Human IgG (APC)
Goat Anti-Human IgG (Cy5)
Goat Anti-Human IgG (TRITC)
Goat Anti-Human IgG (PE)
Goat Anti-Human IgG (FITC)
Mouse Anti-Human IgE epsilon chain Antibody
Serplulimab (anti-PDCD1)
Cetrelimab (anti-PDCD1)
Geptanolimab (anti-PDCD1)
Goat Anti-Human IgG Fc Antibody
Budigalimab (anti-PD-1)
Sasanlimab (anti-PD-1)
Balstilimab (anti-PD-1)
Pimivalimab (anti-PD-1)
Ezabenlimab (anti-PD-1)
Toripalimab (anti-PD-1)
Human IgG2-Kappa
Human IgG3-kappa
Finotonlimab (anti-PD-1)
PD1 Mouse mAb (FITC)
PD1 Mouse mAb (PE)
PD1 Mouse mAb (APC)
PD1 Mouse mAb (Biotin)
Peresolimab (anti-PD-1)
Rosnilimab (anti-PD-1)
PD1/CD279 Mouse mAb
Human IgG1-kappa, anti-Spike RBD
Human IgG4-kappa
Goat Anti-Human IgG (AF647)
Goat Anti-Human IgG (AF405)
Human IgG (FITC)
Human IgG (APC)
Human IgG1(P331S/E430G)-kappa, anti-HEL
Human IgG (PE)
Human IgG1(D265A/N297A)-kappa, anti-HEL
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL
Human IgG1(F405L)-kappa, anti-HEL
Human IgG1(N297Q)-kappa, anti-HEL
Human IgG (Biotin)
Human IgG1(N297S)-kappa, anti-HEL
Human IgG1(E233A/L235A)-kappa, anti-HEL
Human IgG1(K214R/N297A)-kappa, anti-HEL
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL
Human IgG1(L234F/L235E)-kappa, anti-HEL
Human IgG1(D265A)-kappa, anti-HEL
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL
Human IgG1(D270N)-kappa, anti-HEL
Human IgG4(S228P)-kappa, anti-HEL
Human IgG1(N297A)-kappa, anti-HEL
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL
Human IgG1-lambda1, anti-Spike RBD
Human IgG1-lambda2, anti-Spike RBD
Iparomlimab (anti-PDCD1)
Prolgolimab (anti-PDCD1)
Nofazinlimab (anti-PDCD1)
Rulonilimab (anti-PDCD1)
Goat Anti-Human IgG (AF555)
Human IgG1-kappa (AF647), anti-Spike RBD
Human IgG1-kappa (AF405), anti-Spike RBD
Human IgG1-kappa (APC), anti-Spike RBD
Human IgG1-kappa (Biotin), anti-Spike RBD
Human IgG1-kappa (AF700), anti-Spike RBD
Human IgG1-kappa (FITC), anti-Spike RBD
Human IgG1-kappa (AF555), anti-Spike RBD
Centrose patent anti-dysadherin (anti-Dysadherin)
Human IgG (AF647)
Human IgG (AF488)
Human IgG (AF700)
Human IgG (AF405)
Goat Anti-Human IgG (AF488)
Goat Anti-Human IgG Fc (Cy5)
Goat Anti-Human IgG Fc (AF555)
Goat Anti-Human IgG Fc (TRITC)
Goat Anti-Human IgG Fc (AF700)
Goat Anti-Human IgG Fc (AF405)
Goat Anti-Human IgG Fc (Biotin)
Goat Anti-Human IgG Fc (AF647)
Goat Anti-Human IgG Fc (FITC)
Human IgG (AF555)